|
US565354A
(en)
|
|
1896-08-04 |
|
James h |
|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
WO1980001139A1
(en)
|
1978-12-06 |
1980-06-12 |
Svedman Paul |
Device for treating tissues,for example skin
|
|
US4355023A
(en)
|
1980-09-30 |
1982-10-19 |
The Massachusetts General Hospital |
Antibody fragment compositions and process
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4470925A
(en)
|
1982-05-05 |
1984-09-11 |
E. I. Du Pont De Nemours And Company |
Immunoglobulin half-molecules and process for producing hybrid antibodies
|
|
US4462334A
(en)
|
1982-08-19 |
1984-07-31 |
Kim Ho K |
Solar animal structure
|
|
AT379688B
(de)
|
1982-11-22 |
1986-02-10 |
List Hans |
Sensorelement zur bestimmung des o2-gehaltes einer probe
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
EP0174810B1
(en)
|
1984-09-10 |
1993-07-21 |
HSC Research Development Corporation |
Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein dna
|
|
US4837306A
(en)
|
1985-02-25 |
1989-06-06 |
The Ontario Cancer Institute |
Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen
|
|
GB8509978D0
(en)
|
1985-04-18 |
1985-05-30 |
Juhasz L |
Wound dressings
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
US5565354A
(en)
|
1986-09-05 |
1996-10-15 |
Sandoz Ltd. |
Production of human monoclonal antibodies specific for hepatitis B surface antigen
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US5606040A
(en)
|
1987-10-30 |
1997-02-25 |
American Cyanamid Company |
Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
|
|
US5053394A
(en)
|
1988-09-21 |
1991-10-01 |
American Cyanamid Company |
Targeted forms of methyltrithio antitumor agents
|
|
WO1990003430A1
(en)
|
1988-09-23 |
1990-04-05 |
Cetus Corporation |
Cell culture medium for enhanced cell growth, culture longevity and product expression
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5211657A
(en)
|
1988-11-07 |
1993-05-18 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5399483A
(en)
|
1989-03-30 |
1995-03-21 |
Suntory Limited |
Expression of MDR-related gene in yeast cell
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
US5434075A
(en)
|
1992-03-20 |
1995-07-18 |
Board Of Trustees Of The University Of Illinois |
Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
DK0617706T3
(da)
|
1991-11-25 |
2001-11-12 |
Enzon Inc |
Multivalente antigenbindende proteiner
|
|
US5407686A
(en)
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
US6436078B1
(en)
|
1994-12-06 |
2002-08-20 |
Pal Svedman |
Transdermal perfusion of fluids
|
|
ATE244763T1
(de)
|
1992-02-11 |
2003-07-15 |
Cell Genesys Inc |
Erzielen von homozygotem durch zielgerichtete genetische ereignisse
|
|
US6231881B1
(en)
|
1992-02-24 |
2001-05-15 |
Anton-Lewis Usala |
Medium and matrix for long-term proliferation of cells
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
IT1257893B
(it)
|
1992-06-17 |
1996-02-16 |
Ist Superiore Sanita |
Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
|
|
EP0669836B1
(en)
|
1992-11-13 |
1996-07-03 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
|
|
GB2272645B8
(en)
|
1992-11-23 |
2010-02-10 |
Johnson & Johnson Medical |
Wound dressing
|
|
AU691811B2
(en)
|
1993-06-16 |
1998-05-28 |
Celltech Therapeutics Limited |
Antibodies
|
|
AU704183B2
(en)
|
1994-01-05 |
1999-04-15 |
Arqule, Inc. |
Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
|
|
GB9403135D0
(en)
|
1994-02-18 |
1994-04-06 |
Univ Glasgow |
Wound healing device
|
|
CA2190121A1
(en)
|
1994-03-15 |
1995-09-21 |
Edith Mathiowitz |
Polymeric gene delivery system
|
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
US5686578A
(en)
|
1994-08-05 |
1997-11-11 |
Immunomedics, Inc. |
Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
|
|
US5712171A
(en)
|
1995-01-20 |
1998-01-27 |
Arqule, Inc. |
Method of generating a plurality of chemical compounds in a spatially arranged array
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US6413479B1
(en)
*
|
1996-06-28 |
2002-07-02 |
Matsushita Electric Works, Ltd. |
Reforming apparatus for making a co-reduced reformed gas
|
|
US5904659A
(en)
|
1997-02-14 |
1999-05-18 |
Exogen, Inc. |
Ultrasonic treatment for wounds
|
|
US6152142A
(en)
|
1997-02-28 |
2000-11-28 |
Tseng; Scheffer C. G. |
Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
|
|
DE19722075C1
(de)
|
1997-05-27 |
1998-10-01 |
Wilhelm Dr Med Fleischmann |
Vorrichtung zur Applikation von Wirkstoffen an einer Wundoberfläche
|
|
US6420622B1
(en)
|
1997-08-01 |
2002-07-16 |
3M Innovative Properties Company |
Medical article having fluid control film
|
|
US6071267A
(en)
|
1998-02-06 |
2000-06-06 |
Kinetic Concepts, Inc. |
Medical patient fluid management interface system and method
|
|
DE69937291T2
(de)
|
1998-04-02 |
2008-07-10 |
Genentech, Inc., South San Francisco |
Antikörpervarianten und fragmente davon
|
|
GB9808836D0
(en)
|
1998-04-27 |
1998-06-24 |
Amersham Pharm Biotech Uk Ltd |
Microfabricated apparatus for cell based assays
|
|
JP4220058B2
(ja)
|
1998-06-30 |
2009-02-04 |
浜松ホトニクス株式会社 |
半導体位置検出器
|
|
US6479072B1
(en)
|
1999-02-11 |
2002-11-12 |
The General Hospital Corporation |
Microfabricated membranes and matrices
|
|
US6277574B1
(en)
*
|
1999-04-09 |
2001-08-21 |
Incyte Genomics, Inc. |
Genes associated with diseases of the kidney
|
|
KR20030009325A
(ko)
|
1999-11-29 |
2003-01-29 |
힐-롬 서비시즈, 인크. |
상처 치료 장치
|
|
PT1309726E
(pt)
|
2000-03-30 |
2010-03-08 |
Whitehead Biomedical Inst |
Mediadores de interferência por rna específicos de sequência de rna
|
|
EP1290028B1
(en)
|
2000-06-05 |
2009-12-23 |
The Brigham And Women's Hospital, Inc. |
A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF
|
|
WO2001096361A1
(en)
*
|
2000-06-12 |
2001-12-20 |
University Of Maryland Biotechnology Institute |
Method of controlling the binding of calmyrin to presenilin
|
|
WO2001098361A2
(en)
|
2000-06-22 |
2001-12-27 |
Genentech, Inc. |
Agonist anti-trk-c monoclonal antibodies
|
|
WO2002029106A2
(en)
|
2000-10-03 |
2002-04-11 |
California Institute Of Technology |
Microfluidic devices and methods of use
|
|
WO2002040541A2
(en)
|
2000-10-27 |
2002-05-23 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
|
US6855135B2
(en)
|
2000-11-29 |
2005-02-15 |
Hill-Rom Services, Inc. |
Vacuum therapy and cleansing dressing for wounds
|
|
US6685681B2
(en)
|
2000-11-29 |
2004-02-03 |
Hill-Rom Services, Inc. |
Vacuum therapy and cleansing dressing for wounds
|
|
US8015677B2
(en)
|
2000-12-01 |
2011-09-13 |
Aard-Balm Limited |
Embalming fluid
|
|
WO2002053290A2
(en)
|
2001-01-08 |
2002-07-11 |
President And Fellows Of Harvard College |
Valves and pumps for microfluidic systems and method for making microfluidic systems
|
|
AU2002243663A1
(en)
|
2001-02-02 |
2002-08-19 |
The Regents Of The University Of Michigan |
Micro-tubular materials and cell constructs
|
|
US6695824B2
(en)
|
2001-04-16 |
2004-02-24 |
The United States Of America As Represented By The Secretary Of The Army |
Wound dressing system
|
|
US7723560B2
(en)
|
2001-12-26 |
2010-05-25 |
Lockwood Jeffrey S |
Wound vacuum therapy dressing kit
|
|
CA2468912A1
(en)
|
2001-12-26 |
2003-07-17 |
Hill-Rom Services, Inc. |
Vented vacuum bandage and method
|
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
ES2350687T3
(es)
|
2002-07-03 |
2011-01-26 |
Ono Pharmaceutical Co., Ltd. |
Composiciones de inmunopotenciación.
|
|
JP2006502110A
(ja)
|
2002-07-03 |
2006-01-19 |
イミュノジェン・インコーポレーテッド |
非放出Ｍｕｃ１およびＭｕｃ１６に対する抗体、およびその使用
|
|
AU2003285878B2
(en)
|
2002-11-07 |
2011-04-28 |
Immunogen, Inc. |
Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
|
|
CA2508660C
(en)
|
2002-12-23 |
2013-08-20 |
Wyeth |
Antibodies against pd-1 and uses therefor
|
|
KR20060031809A
(ko)
|
2003-06-09 |
2006-04-13 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
암 치료 및 진단용 조성물 및 방법
|
|
GB0325130D0
(en)
|
2003-10-28 |
2003-12-03 |
Smith & Nephew |
Apparatus with scaffold
|
|
EP1702061A4
(en)
|
2003-11-24 |
2007-05-02 |
Univ Rockefeller |
METHOD OF INSULATING A SELF-RENEWING, MULTIPOTENTIAL, SLOWLY CIRCULATING CELL
|
|
HUE026132T2
(en)
|
2004-01-07 |
2016-05-30 |
Novartis Vaccines & Diagnostics Inc |
M-CSF-specific monoclonal antibody and its uses
|
|
WO2005079257A2
(en)
|
2004-02-12 |
2005-09-01 |
Dexcom, Inc. |
Biointerface with macro- and micro- architecture
|
|
GB0416168D0
(en)
*
|
2004-07-20 |
2004-08-18 |
Vernalis Cambridge Ltd |
Pyrmidothiophene compounds
|
|
CA2998412C
(en)
|
2004-11-12 |
2024-01-02 |
Cambridge University Technical Services Ltd. |
Methods and means related to cancer stem cells
|
|
US20070099209A1
(en)
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
CA2612021A1
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
SI2772535T1
(sl)
|
2006-05-31 |
2022-08-31 |
Children's Medical Center Corporation |
ABC5 pozitivne mezenhimske matične celice kot imunomodulatorji
|
|
CA2698597A1
(en)
|
2006-09-07 |
2008-03-13 |
Stemline Therapeutics, Inc. |
Monitoring cancer stem cells
|
|
ES2687270T3
(es)
|
2007-04-12 |
2018-10-24 |
The Brigham And Women's Hospital, Inc. |
Fijación como objetivo de ABCB5 para la terapia del cáncer
|
|
EP3734281A3
(en)
|
2008-11-14 |
2021-01-27 |
The Brigham and Women's Hospital, Inc. |
Therapeutic and diagnostic methods relating to cancer stem cells
|
|
EP2964238B1
(en)
|
2013-02-19 |
2021-01-13 |
Children's Medical Center Corporation |
Abcb5(+) stem cells for treating ocular disease
|
|
MX378814B
(es)
|
2013-05-10 |
2025-03-11 |
Childrens Medical Center |
Armazón de colágeno y glicosaminoglicano coinjertado con una población de células madre abcb5+ y usos del mismo.
|